Anthracycline-induced cardiotoxicity in women without cardiovascular diseases: molecular and genetic predictors-Reference-Cited by-同舟云学术

Anthracycline-induced cardiotoxicity in women without cardiovascular diseases: molecular and genetic predictors

Published:2021-11-16 Issue: Volume: Page:1-10
ISSN:0001-5385
Container-title:Acta Cardiologica
language:en
Short-container-title:Acta Cardiologica

Author:

Kopeva Kristina V.¹,Grakova Elena V.¹,Shilov Sergey N.²,Berezikova Ekaterina N.²,Popova Anna A.²,Neupokoeva Maria N.²,Ratushnyak Elena T.²,Teplyakov Alexander T.¹

Affiliation:

1. Department of Myocardial Pathology (Tomsk, Russian Federation), Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia

2. Department of Pathological Physiology and Clinical Pathophysiology (Novosibirsk, Russian Federation), Novosibirsk State Medical University, Novosibirsk, Russia

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00015385.2021.2003061

Reference37 articles.

1. European Commission. ECIS - European Cancer Information System 2019. Available online at: https://ecis.jrc.ec.europa.eu/.

2. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

3. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

4. Cancer Therapy–Related Cardiac Dysfunction and Heart Failure

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Pharmacogenomics in Drug-Induced Cardiovascular Toxicity;Advances in Biochemistry in Health and Disease;2024

2. New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review;Cancers;2023-06-22

3. Tetranectin as a potential novel prognostic biomarker in anthracycline-related cardiac dysfunction;Heart and Vessels;2023-06-13

4. Focus issue on cardiomyopathies;Acta Cardiologica;2022-10-21

5. Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future;Frontiers in Cardiovascular Medicine;2022-10-13